Zobrazeno 1 - 10
of 40
pro vyhledávání: '"HUMAN C1-ESTERASE INHIBITOR"'
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 34-40 (2021)
Hereditary angioedema belongs to the group of rare, orphan, genetically determined defects that represent a significant medical and social problem due to the pronounced impact on the quality of life and potential mortality, as well as the emerging di
Externí odkaz:
https://doaj.org/article/b4e261e7430b4c13b3aba3912d96fc61
Publikováno v:
Annals of Allergy, Asthma & Immunology. 126:707-712
BACKGROUND Recombinant human C1 esterase inhibitor (rhC1-INH) is indicated in the United States for the treatment of acute hereditary angioedema (HAE) attacks in adolescents and adults; it is also indicated in Europe for children aged 2 years and old
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::064484a95be93fc9aa80c4cbd7c7bd7a
https://doi.org/10.1016/j.anai.2021.02.010
https://doi.org/10.1016/j.anai.2021.02.010
Autor:
Tobias M. Suiter, Radana Zachova, Sladjana Andrejevic, Anna Valerieva, Ralph Shapiro, Katarina Hrubiskova, Ljerka Karadza-Lapic, Roman Hakl, Vesna Grivcheva-Panovska, Maria Staevska, D. Soteres, Vinay Mehta, Milos Jesenak, Marta Sobotkova, F. Ida Hsu, Jeffrey Rumbyrt, Andrea Zanichelli, Raffi Tachdjian
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:799-802
Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec0619934bfec4ec2bba07735f3efe8
https://doi.org/10.1016/j.jaip.2019.08.011
https://doi.org/10.1016/j.jaip.2019.08.011
Autor:
Vesna Grivcheva-Panovska, Markus Magerl, Henriette Farkas, Avner Reshef, Stephen Fritz, Dumitru Moldovan, Bruno Giannetti, Aharon Kessel, Vaclava Gutova, Anurag Relan, Shmuel Kivity, Maria Klimaszewska-Rembiasz
Publikováno v:
Pediatric Allergy and Immunology
Background Attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1‐INH‐HAE) usually begin during childhood or adolescence. However, limited data are available regarding indications and modalities of treatment of childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52ca4a08472520efcd436f5a96cac7d
https://doi.org/10.1111/pai.13065
https://doi.org/10.1111/pai.13065
Publikováno v:
Allergy and Asthma Proceedings. 39:359-364
Background Hereditary angioedema (HAE) may occur at or spread to multiple anatomic locations during an acute attack. Recombinant human C1 esterase inhibitor (rhC1-INH) is approved for treating acute HAE attacks. Objective To examine the time to the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e49f286f0fc4576939d66835c53afb1
https://doi.org/10.2500/aap.2018.39.4151
https://doi.org/10.2500/aap.2018.39.4151
Autor:
Anneza Panagiotou, Christoph Kaiser, Tobias Breidthardt, Michael Osthoff, Ingmar Heijnen, Leo H. Bonati, Stephan Moser, Marten Trendelenburg, Raban Jeger, Gregor Fahrni
Publikováno v:
JACC. Cardiovascular interventions. 13(7)
This study sought to determine the efficacy profile and safety of recombinant human C1 esterase inhibitor (rhC1INH) in the prevention of contrast-associated acute kidney injury after elective coronary angiography.Contrast-associated acute kidney inju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ae3657fc0440201b681561c184796f
https://pubmed.ncbi.nlm.nih.gov/32171716
https://pubmed.ncbi.nlm.nih.gov/32171716
Autor:
Anneza Panagiotou, Marten Trendelenburg, Gregor Fahrni, Raban Jeger, Tobias Breidthardt, Michael Osthoff, Stephan Moser, Leo H. Bonati, Christoph Kaiser, Ingmar Heijnen
Publikováno v:
Nephrology Dialysis Transplantation. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f19833b1dc036469de0c0ee42b2f3f
https://doi.org/10.1093/ndt/gfz101.sao039
https://doi.org/10.1093/ndt/gfz101.sao039
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Allergy, Asthma & Immunology. 125:S25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb5d9a58111b856882f2a4fd7d952ed9
https://doi.org/10.1016/j.anai.2020.08.403
https://doi.org/10.1016/j.anai.2020.08.403
Publikováno v:
Expert review of clinical immunology. 14(9)
Hereditary angioedema (HAE) due to C1 inhibitor (C1-INH) deficiency is a debilitating and potentially lethal disease. Management includes on-demand treatment of angioedema and their prophylaxis. Plasma derived C1-INH is an established treatment for b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b423da340bf0c86c49900c0e57b430a
https://pubmed.ncbi.nlm.nih.gov/30021471
https://pubmed.ncbi.nlm.nih.gov/30021471